Monday, 28 January 2013

Yahoo! Finance: Biotechnology Industry News: Anacor Pharmaceuticals to Hold Conference Call Tomorrow, January 29, 2013 at 8AM ET to Discuss Preliminary Results from the First Phase 3 Study of Tavaborole for the Treatment of Onychomycosis

Yahoo! Finance: Biotechnology Industry News
The latest news on the Biotechnology industry from Yahoo! Finance
Anacor Pharmaceuticals to Hold Conference Call Tomorrow, January 29, 2013 at 8AM ET to Discuss Preliminary Results from the First Phase 3 Study of Tavaborole for the Treatment of Onychomycosis
Jan 29th 2013, 00:37

[Business Wire] - Anacor Pharmaceuticals will release preliminary results from the first of two Phase 3 studies of tavaborole for onychomycosis tomorrow, January 29, 2013 at approximately 7:00 a.m.

You are receiving this email because you subscribed to this feed at blogtrottr.com.

If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions

No comments:

Post a Comment